p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
出版年份 2013 全文链接
标题
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 110, Issue 3, Pages 656-667
出版商
Springer Nature
发表日期
2013-11-27
DOI
10.1038/bjc.2013.742
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surf the Post-translational Modification Network of p53 Regulation
- (2012) Bo Gu et al. International Journal of Biological Sciences
- P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells
- (2012) K. Bajbouj et al. JOURNAL OF NEURO-ONCOLOGY
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress
- (2012) André Brandl et al. Journal of Molecular Cell Biology
- Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer Cells
- (2011) Bulbul Pandit et al. AMERICAN JOURNAL OF PATHOLOGY
- Sirtuin 1 in malignant transformation: Friend or foe?
- (2011) Yujiang Fang et al. CANCER LETTERS
- Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation
- (2011) S Häcker et al. ONCOGENE
- Inhibitors of HDACs - Effective Drugs Against Cancer?
- (2010) S. Muller et al. CURRENT CANCER DRUG TARGETS
- Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression
- (2010) Chithra D. Palani et al. INVESTIGATIONAL NEW DRUGS
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- The C terminus of p53 binds the N-terminal domain of MDM2
- (2010) Masha V Poyurovsky et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- NF-κB addiction and its role in cancer: ‘one size does not fit all’
- (2010) M M Chaturvedi et al. ONCOGENE
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- HDACi – Targets beyond chromatin
- (2009) Marc Buchwald et al. CANCER LETTERS
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Rational Combinations Using HDAC Inhibitors
- (2009) M. Bots et al. CLINICAL CANCER RESEARCH
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
- (2008) Avi Ashkenazi NATURE REVIEWS DRUG DISCOVERY
- Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
- (2007) F Condorelli et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started